Discover the newest research about AI innovations in ๐งช Drug Discovery.
Fragment-based drug design revolutionizes drug discovery, enhancing speed and efficiency post-COVID. Key insights from recent research. ๐๐ฌ
AI agents revolutionizing cancer research: optimizing drug design, proposing therapies, and tackling complex challenges. ๐ค๐
Revolutionary DTA Prediction: PMHGT-DTA Framework Enhances Drug Discovery with 3D Graphs and Cross-Attention! ๐๐ฌ
AI accelerates monoclonal antibody design, aiding in the fight against viral infections like RSV and avian influenza. ๐ฆ ๐
Fungal virulence factors dataset aids IBD antifungal drug discovery. 18,072 VFs identified; 390 potential VFs predicted. ๐ฆ ๐
Technological advancements in antibody therapeutics: 144 FDA-approved drugs, $267B sales, and AI-driven discoveries. ๐๐
Children’s drug development: 32.7% tumor reduction via imaging data. Optimized pricing ensures accessibility and R&D efficiency. ๐๐
Siamese Neural Networks enhance SARS-CoV-2 antibody interaction analysis, achieving 90% accuracy in predicting stable complexes. ๐ค๐ฌ
New antibiotic enterololin targets inflammatory bowel disease, developed with AI insights. Promising treatment for Crohn’s patients. ๐ฆ ๐
AI tools are aiding scientists in tracking disease origins and immune responses, enhancing treatment strategies. ๐งฌ๐
